Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

DepoAmikacin phase I trial completed

April 19, 1996

Abelcet trial results in children favorable

April 19, 1996

Cefdinir close to filing in U.S.

April 19, 1996

New patent issued to Interferon Sciences

April 12, 1996

Anti-HSV compound karalicin

April 12, 1996

Dutch approval for Amphocil

April 12, 1996

S-28679, a new interferon biosynthesis inducer from 3M

April 12, 1996

AmBisome approved for marketing in Spain

April 12, 1996

Mentax approvable for athlete's foot

April 12, 1996

New antifungals isolated from actinomycetes at Schering-Plough

April 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for May 13, 2025.
Little bite from voluntary most-favored nation Rx pricing order
BioWorld
After a week of hype, the most-favored nation (MFN) drug pricing executive order (EO) U.S. President Donald Trump signed May 12 has a lot of bark but little bite,...
AACR 2025: Induced proximity strategy, beyond degraders
BioWorld
Targeted protein degradation has yet to notch its first approval. But with more than two dozen agents now in clinical trials, the strategy’s ultimate clinical...
China’s NMPA gives thumbs up to Remegen’s ADC targeting HER2
BioWorld
China’s National Medical Products Administration has approved Remegen Co. Ltd.’s antibody-drug conjugate (ADC), disitamab vedotin (RC-48), for treatment of...